CBD Life Sciences (CBD Life Sciences) EV-to-EBIT : -9.49 (As of May. 26, 2024)

CBD Life Sciences EV-to-EBIT Chart

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
EV-to-EBIT	Get a 7-Day Free Trial											-4.12	-2.38	-2.91	-	-18.09

Competitive Comparison of CBD Life Sciences's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CBD Life Sciences's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's EV-to-EBIT falls into.

CBD Life Sciences EV-to-EBIT Calculation

CBD Life Sciences's EV-to-EBIT for today is calculated as:

CBD Life Sciences's current Enterprise Value is $0.95 Mil.
CBD Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences  (OTCPK:CBDL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

CBD Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2015 is calculated as:

CBD Life Sciences's Enterprise Value for the quarter that ended in Sep. 2015 was $0.00 Mil.
CBD Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description